TransMedics

TransMedics is a Massachusetts-based medical device firm that develops and commercializes portable warm blood perfusion systems for living organ transplants.

Business Model:

Revenue: $71.8M

Employees: 51-200

Detailed TransMedics Information

Geographic Data

TransMedics headquarters map

Address: 200 Minuteman Road

City: Andover

State: MA

Zip: 01810

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$2M

Raised Total:

$261M

Metrics

4,661,787Website Global Rank

2,103Website Monthly Traffic

Twitter Followers

Description

TransMedics is a Massachusetts-based medical device firm that develops and commercializes portable warm blood perfusion systems for living organ transplants.

Contact Phone:
+19785520900

Contact Email:

TransMedics went public on 5/1/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
5/1/2019

IPO Valuation:
$324M

Ticker Symbol:
TMDX

IPO Price:
$16/share

Amount Raised:
$90M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2007 Series D $0 Sherbrooke Capital
3i Group
Alta Partners
CB Health Ventures
Flagship Pioneering
POSCO BioVentures
Sagamore Bioventures
Tudor Investments
VantagePoint Capital Partners
Sherbrooke Capital
3i Group
Alta Partners
CB Health Ventures
Flagship Pioneering
POSCO BioVentures
Sagamore Bioventures
Tudor Investments
VantagePoint Capital Partners
9/2022 Post-IPO Debt 1 $60M CIBC Innovation Banking
CIBC Innovation Banking
9/2000 Series A $0 Alta Partners
Chase Capital Partners
MedEquity Investors
Sofinov Societe Financiere D&s;Innovation
Alta Partners
Chase Capital Partners
MedEquity Investors
Sofinov Societe Financiere D&s;Innovation
5/2016 Series F $0 Fayerweather Fund
Fayerweather Fund
Inbio Ventures
Abrams Capital
BioStar Capital
Flagship Pioneering
Kleiner Perkins
Lung Biotechnology
Millhouse
Fayerweather Fund
Fayerweather Fund
Inbio Ventures
Abrams Capital
BioStar Capital
Flagship Pioneering
Kleiner Perkins
Lung Biotechnology
Millhouse
1/2004 Series B 8 $27.6M Sherbrooke Capital
POSCO BioVentures
Novel Bioventures
Flagship Pioneering
CDP Capital Technology Ventures
CB Health Ventures
Alta Partners
3i Group
Sherbrooke Capital
POSCO BioVentures
Novel Bioventures
Flagship Pioneering
CDP Capital Technology Ventures
CB Health Ventures
Alta Partners
3i Group
3/2006 Series C $0 Sherbrooke Capital
3i Group
Alta Partners
CB Health Ventures
Flagship Pioneering
POSCO BioVentures
Sagamore Bioventures
VantagePoint Capital Partners
Sherbrooke Capital
3i Group
Alta Partners
CB Health Ventures
Flagship Pioneering
POSCO BioVentures
Sagamore Bioventures
VantagePoint Capital Partners
5/2019 IPO $91.9M
3/2010 Series E $0 Foundation Capital
Kleiner Perkins
Sherbrooke Capital
Tudor Investments
3i Group
Alta Partners
CB Health Ventures
Excel Venture Management
Flagship Pioneering
POSCO BioVentures
Sagamore Bioventures
VantagePoint Capital Partners
Foundation Capital
Kleiner Perkins
Sherbrooke Capital
Tudor Investments
3i Group
Alta Partners
CB Health Ventures
Excel Venture Management
Flagship Pioneering
POSCO BioVentures
Sagamore Bioventures
VantagePoint Capital Partners
6/2015 Venture Round $20M
4/2020 Post-IPO Debt 1 $2.2M OrbiMed
OrbiMed
9/2015 Venture Round $500k
7/2009 Debt Financing $2.5M
8/2011 Venture Round $6M
11/2009 Debt Financing $3.6M
5/2016 Equity $63.7M Flagship Ventures
Abrams Capital
InBio Ventures
BioStar Ventures
Lung Biotechnology PBC
Kleiner Perkins Caufield Byers
9/2022 Post-IPO Debt $60M
11/2012 Venture Round 4 $36M Abrams Capital
Flagship Pioneering
Hercules Capital
Kleiner Perkins
Abrams Capital
8/2022 Post-IPO Equity $130M
7/2016 Private Equity Round $0 Fayerweather Fund
Abrams Capital
BioStar Capital
Kleiner Perkins
Lung Biotechnology
Flagship Pioneering
Inbio Ventures
Pharmstandard
Fayerweather Fund
Pharmstandard
Fayerweather Fund
Abrams Capital
BioStar Capital
Kleiner Perkins
Lung Biotechnology
Flagship Pioneering
Inbio Ventures
Pharmstandard
Fayerweather Fund
Pharmstandard
7/2016 Private Equity Round 8 $12.5M Fayerweather Fund
Abrams Capital
BioStar Capital
Kleiner Perkins
Lung Biotechnology
Flagship Pioneering
Inbio Ventures
Pharmstandard
Fayerweather Fund
Pharmstandard
Fayerweather Fund
Abrams Capital
BioStar Capital
Kleiner Perkins
Lung Biotechnology
Flagship Pioneering
Inbio Ventures
Pharmstandard
Fayerweather Fund
Pharmstandard
5/2016 Series F 8 $51.2M Fayerweather Fund
Fayerweather Fund
Inbio Ventures
Fayerweather Fund
Fayerweather Fund
Inbio Ventures
3/2010 Series E 12 $36M Foundation Capital
Kleiner Perkins
Foundation Capital
Kleiner Perkins
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research